Analyst Ratings for Zimmer Biomet (ZBH) [Buys]
ZBH Rating Summary
ZBH Price Target Summary
- Highest: $160.00 (JMP Securities)
- Lowest: $109.00 (UBS)
- Average: $137.05
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$137.05 (+14.8%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 47%
Avg. $ Target:
$137.05 (+14.8%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 47%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/14/2023 | Nephron | Chris Pasquale | Upgrade | Buy (Hold) |
145.00 (N/A) |
117.90 (119.43) |
1.3% | Details |
| 8/28/2023 | BTIG | Ryan Zimmerman | Upgrade | Buy (Neutral) |
139.00 (N/A) |
115.24 (119.43) |
3.64% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
